e-learning
resources
Paris 2018
Sunday, 16.09.2018
COPD phenotypes: a1 antitrypsin deficiency and beyond
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The discriminatory capacity of symptoms to distinguish undiagnosed COPD from non-COPD
K. Johnson (Vancouver, Canada), W. Tan (Vancouver, Canada), J. Bourbeau (Montreal, Canada), M. Sadatsafavi (Vancouver, Canada)
Source:
International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Session:
COPD phenotypes: a1 antitrypsin deficiency and beyond
Session type:
Poster Discussion
Number:
576
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Johnson (Vancouver, Canada), W. Tan (Vancouver, Canada), J. Bourbeau (Montreal, Canada), M. Sadatsafavi (Vancouver, Canada). The discriminatory capacity of symptoms to distinguish undiagnosed COPD from non-COPD. 576
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Related content which might interest you:
Comparison between COPD and non-COPD patients with established cardiovascular diseases: A profiling of respiratory symptoms and functional status
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers
Source: Eur Respir J 2014; 43: 54-63
Year: 2004
Symptoms, functional parameters and exercise capacity in COPD patients with frequent and with infrequent exacerbations
Source: Eur Respir J 2003; 22: Suppl. 45, 406s
Year: 2003
Identifying asthma features in severe COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
COPD patients continue to smoke after being diagnosed for COPD
Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence
Year: 2020
Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers
Source: Eur Respir J 2002; 20: 1117-1122
Year: 2002
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Does knowledge of smokers about chronic obstructive pulmonary disease (COPD) differ than nonsmokers?
Source: Eur Respir J 2004; 24: Suppl. 48, 372s
Year: 2004
Comparison of clinical characteristics between stable COPD patients with- and without mild bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 257s
Year: 2002
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013
Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Sensitivity of the clinical COPD questionnaire to measure disease control in COPD patients referred for pulmonary rehabilitation
Source: Annual Congress 2008 - Respiratory mechanics, muscles and breathing; functional status measures and coping styles
Year: 2008
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
The prevalence and clinical characteristics of asthma–COPD overlap syndrome (ACOS) in patients with COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Pathology of small airways in non-COPD smokers with low diffusion capacity and patients with COPD
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD
Source: Eur Respir J 2013; 41: 800-805
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept